LifeMD (LFMD) Competitors $6.08 +0.07 (+1.16%) Closing price 04:00 PM EasternExtended Trading$6.08 0.00 (0.00%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. FTRE, PNTG, CDNA, CSTL, FLGT, INNV, AGL, AUNA, PSNL, and TALKShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Fortrea (FTRE), The Pennant Group (PNTG), CareDx (CDNA), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), InnovAge (INNV), Agilon Health (AGL), Auna (AUNA), Personalis (PSNL), and Talkspace (TALK). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Fortrea The Pennant Group CareDx Castle Biosciences Fulgent Genetics InnovAge Agilon Health Auna Personalis Talkspace Fortrea (NASDAQ:FTRE) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Does the media prefer FTRE or LFMD? In the previous week, LifeMD had 19 more articles in the media than Fortrea. MarketBeat recorded 30 mentions for LifeMD and 11 mentions for Fortrea. Fortrea's average media sentiment score of 0.67 beat LifeMD's score of 0.15 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 6 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 3 Very Positive mention(s) 0 Positive mention(s) 26 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, FTRE or LFMD? LifeMD has lower revenue, but higher earnings than Fortrea. LifeMD is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortrea$2.70B0.35-$328.50M-$11.38-0.91LifeMD$212.45M1.36-$18.88M-$0.21-28.95 Which has more risk & volatility, FTRE or LFMD? Fortrea has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Do insiders and institutionals hold more shares of FTRE or LFMD? 35.5% of LifeMD shares are owned by institutional investors. 0.4% of Fortrea shares are owned by insiders. Comparatively, 18.4% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is FTRE or LFMD more profitable? LifeMD has a net margin of -2.41% compared to Fortrea's net margin of -37.57%. Fortrea's return on equity of 5.25% beat LifeMD's return on equity.Company Net Margins Return on Equity Return on Assets Fortrea-37.57% 5.25% 1.72% LifeMD -2.41%N/A -8.11% Do analysts rate FTRE or LFMD? Fortrea presently has a consensus target price of $11.50, suggesting a potential upside of 11.65%. LifeMD has a consensus target price of $13.17, suggesting a potential upside of 116.56%. Given LifeMD's stronger consensus rating and higher possible upside, analysts clearly believe LifeMD is more favorable than Fortrea.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortrea 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.17LifeMD 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryLifeMD beats Fortrea on 10 of the 16 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$288.31M$7.56B$5.73B$10.28BDividend YieldN/A2.86%5.88%4.63%P/E Ratio-28.9577.1076.6726.53Price / Sales1.3637.07525.87121.13Price / CashN/A24.1937.2060.52Price / Book-67.567.1713.946.31Net Income-$18.88M$241.92M$3.29B$271.37M7 Day Performance2.18%1.42%0.64%2.11%1 Month Performance-5.44%1.97%4.32%6.67%1 Year Performance16.92%2.13%84.14%27.85% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD3.4552 of 5 stars$6.08+1.2%$13.17+116.6%+17.2%$288.31M$212.45M-28.95230FTREFortrea2.5123 of 5 stars$10.32-11.3%$12.78+23.8%-53.6%$1.06B$2.70B-0.9115,500PNTGThe Pennant Group4.2276 of 5 stars$24.51+0.9%$34.40+40.4%-29.5%$839.51M$695.24M31.427,000CDNACareDx4.2747 of 5 stars$13.34-3.5%$27.67+107.4%-52.3%$735.60M$333.79M13.08740Positive NewsCSTLCastle Biosciences2.442 of 5 stars$24.06+2.1%$37.00+53.8%-29.7%$683.43M$332.07M-68.74540Positive NewsFLGTFulgent Genetics4.0606 of 5 stars$22.27+1.5%$25.33+13.8%-0.7%$671.87M$283.47M-13.421,313Positive NewsINNVInnovAge0.5197 of 5 stars$4.03+6.3%$5.00+24.1%-12.4%$511.70M$763.85M-17.522,350AGLAgilon Health2.3689 of 5 stars$1.26+4.6%$3.07+144.7%-65.8%$497.31M$6.06B-1.631,076AUNAAuna3.6906 of 5 stars$6.35-0.2%$10.70+68.5%-12.5%$470.72M$1.17B7.2114,842PSNLPersonalis4.0209 of 5 stars$5.32+1.5%$7.42+39.4%+6.3%$464.67M$84.61M-4.16400TALKTalkspace3.9708 of 5 stars$2.67+2.3%$4.50+68.5%+30.4%$437.09M$187.59M133.57500Positive News Related Companies and Tools Related Companies Fortrea Competitors The Pennant Group Competitors CareDx Competitors Castle Biosciences Competitors Fulgent Genetics Competitors InnovAge Competitors Agilon Health Competitors Auna Competitors Personalis Competitors Talkspace Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFMD Stock Alerts